Sepsis-associated acute kidney injury: A bibliometric analysis of the global research output and collaboration network (2013-2023)

Abstract

Objective: To explore the current status of sepsis-associated acute kidney injury (SA-AKI) research and predict its future research directions.

Methods: The bibliometric overview of publications was conducted in the field of SA-AKI based on Web of Science Core Collection database from January 2013 to August 2023. This study employed software such as CiteSpace and VOSviewer to conduct bibliometric and visualization analysis of the included literature, including publication trends, geographic distribution characteristics, author contributions, citations, funding sources characteristics, and keyword clustering.

Results: A total of 6509 articles were analyzed, and the number of publications and citations increased from 2013 to 2022. The United States had the highest number of publications in SA-AKI, while France was the country with the highest number of citations per publication. Keyword clustering analysis showed that the pathophysiology and definition of SA-AKI were the research focus, and the research hotspots were "machine learning", "vitamin C", "kinase", "hemodynamics", "renal microcirculation" and "mitochondria". Literature coupling analysis indicated that exploring the management and treatment of SA-AKI was the research frontier.

Conclusions: Over the past decade, SA-AKI research has shown a upward trend in terms of the number of publication. Research primarily focuses on exploring mechanisms and improving early warning systems. Mechanisms involve microcirculatory dysfunction, inflammation, and other pathophysiological factors. Future recommendations include continuing basic research, achieving clinical application of novel biomarkers, and prioritizing renal recovery mechanisms in treatment strategies.

Keywords

Sepsis / Kidney injury / Research trends / Visual analysis / Bibliometrics

Data availability statement

The data supporting the findings of this study are available from the corresponding author upon request.

Publisher’s note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

[1] Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H. Sepsis-associated acute kidney injury. Crit Care Clin 2021; 37(2):279-301.

[2] Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39(2):165-228.

[3] Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294(7):813-818.

[4] Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet 2019; 394(10212):1949-1964.

[5] Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, et al. Sepsis-associated acute kidney injury:Consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol 2023; 19(6):401-417.

[6] Ninkov A, Frank JR, Maggio LA. Bibliometrics: Methods for studying academic publishing. Perspect Med Educ 2022; 11(3):173-176.

[7] Thompson DF, Walker CK. A descriptive and historical review of bibliometrics with applications to medical sciences. Pharmacotherapy 2015; 35(6):551-559.

[8] Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021;372:n71.

[9] Poston JT, Koyner JL.Sepsis associated acute kidney injury. BMJ 2019;364:k4891.

[10] Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315(8):775-787.

[11] Zhao WJ, Tan RZ, Gao J, Su H, Wang L, Liu J. Research on the global trends of COVID-19 associated acute kidney injury: A bibliometric analysis. Ren Fail 2024; 46(1):2338484.

[12] Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA. Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 2019; 96(5):1083-1099.

[13] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395(10229):1054-1062.

[14] Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intensive Care Med 2015; 41(8):1411-1423.

[15] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315(8):801-810.

[16] Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43(3):304-377.

[17] Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med 2017; 43(6):816-828.

[18] Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, et al. A unified theory of sepsis-induced acute kidney injury: Inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014; 41(1):3-11.

[19] Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012; 367(2):124-134.

[20] Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the global burden of disease study. Lancet 2020; 395(10219):200-211.

[21] Kuwabara S, Goggins E, Okusa MD. The pathophysiology of sepsis-associated AKI. Clin J Am Soc Nephrol 2022; 17(7):1050-1069.

[22] Lu H, Chen Y, Wang X, Yang Y, Ding M, Qiu F.Circular RNA HIPK3 aggravates sepsis-induced acute kidney injury via modulating the microRNA-338/forkhead box A1 axis. Bioengineered 2022; 13(3):4798-4809.

[23] Chen X, Liu Z, Huang L, Li Z, Dai X. Targeting the mechanism of IRF3 in sepsis-associated acute kidney injury via the Hippo pathway. Int Immunopharmacol 2023;122:110625.

[24] Luther T, Bülow-Anderberg S, Persson P, Franzén S, Skorup P, Wernerson A, et al. Renal mitochondrial dysfunction in ovine experimental sepsis-associated acute kidney injury. Am J Physiol Renal Physiol 2023; 324(6):F571-580.

[25] Li B, Xia Y, Mei S, Ye Z, Song B, Yan X, et al. Histone H3K 27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI. Theranostics 2023; 13(6):1860-1875.

[26] Uchida T, Yamada M, Inoue D, Kojima T, Yoshikawa N, Suda S, et al. Involvement of innate immune system in the pathogenesis of sepsis-associated acute kidney injury. Int J Mol Sci 2023; 24(15):12465.

[27] Nusshag C, Wei C, Hahm E, Hayek SS, Li J, Samelko B, et al. suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury. JCI Insight 2023; 8(7):e165740.

[28] Li Z, Ludwig N, Thomas K, Mersmann S, Lehmann M, Vestweber D, et al. The pathogenesis of ischemia-reperfusion induced acute kidney injury depends on renal neutrophil recruitment whereas sepsis-induced AKI does not. Front Immunol 2022;13:843782.

[29] Xu H, Wang Z. MicroRNA-23a-3p ameliorates acute kidney injury by targeting FKBP5 and NF-κB signaling in sepsis. Cytokine 2022;155:155898.

[30] Li N, Lin G, Zhang H, Sun J, Gui M, Liu Y, et al. Lyn attenuates sepsis-associated acute kidney injury by inhibition of phospho-STAT3 and apoptosis. Biochem Pharmacol 2023;211:115523.

[31] Sun J, Ge X, Wang Y, Niu L, Tang L, Pan S. USF 2 knockdown downregulates THBS1 to inhibit the TGF-β signaling pathway and reduce pyroptosis in sepsis-induced acute kidney injury. Pharmacol Res 2022;176:105962.

[32] Tan C, Gu J, Li T, Chen H, Liu K, Liu M, et al. Inhibition of aerobic glycolysis alleviates sepsis-induced acute kidney injury by promoting lactate/Sirtuin 3/AMPK-regulated autophagy. Int J Mol Med 2021; 47(3):19.

[33] Tsuji N, Tsuji T, Yamashita T, Hayase N, Hu X, Yuen PS, et al. BAM15 treats mouse sepsis and kidney injury, linking mortality, mitochondrial DNA, tubule damage, and neutrophils. J Clin Invest 2023; 133(7):e152401.

[34] Xie Z, Wei L, Chen J, Chen Z. Calcium dobesilate alleviates renal dysfunction and inflammation by targeting nuclear factor kappa B (NF-κB) signaling in sepsis-associated acute kidney injury. Bioengineered 2022; 13(2):2816-2826.

[35] Koo JH, Yu HC, Nam S, Kim DC, Lee JH. Casein kinase 2 alpha inhibition protects against sepsis-induced acute kidney injury. Int J Mol Sci 2023; 24(12):9783.

[36] Chen Y, Wei W, Fu J, Zhang T, Zhao J, Ma T. Forsythiaside A ameliorates sepsis-induced acute kidney injury via anti-inflammation and antiapoptotic effects by regulating endoplasmic reticulum stress. BMC Complement Med Ther 2023; 23(1):35.

[37] Guo J, Wang R, Min F. Ginsenoside Rg 1 ameliorates sepsis-induced acute kidney injury by inhibiting ferroptosis in renal tubular epithelial cells. J Leukoc Biol 2022; 112(5):1065-1077.

[38] Hasson DC, Watanabe-Chailland M, Romick-Rosendale L, Koterba A, Miner DS, Lahni P, et al. Choline supplementation attenuates experimental sepsis-associated acute kidney injury. Am J Physiol Renal Physiol 2022; 323(3):F255-271.

[39] Pickkers P, Mehta RL, Murray PT, Joannidis M, Molitoris BA, Kellum JA, et al. Effect of human recombinant alkaline phosphatase on 7-day creatinine clearance in patients with sepsis-associated acute kidney injury: A randomized clinical trial. JAMA 2018; 320(19):1998-2009.

[40] Forni LG, Darmon M, Ostermann M, Oudemans-Van Straaten HM, Pettilä V, Prowle JR, et al. Renal recovery after acute kidney injury. Intensive Care Med 2017; 43(6):855-866.